In particular, the IDH1 gene shows a Y272C somatic variant; this gene is known to be frequently mutated in glioma, cholangiocarcinoma, chondrosarcoma, and acute myeloid leukemia, but in those diseases the recurrent mutations is a gain-of-function point mutation at arginine 132. The gene discussed is IDH1; the disease is central nervous system cancer.